Your browser doesn't support javascript.
loading
Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance.
Ridker, Paul M; Lei, Lei; Louie, Michael J; Haddad, Tariq; Nicholls, Stephen J; Lincoff, A Michael; Libby, Peter; Nissen, Steven E.
Affiliation
  • Ridker PM; Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (P.M.R., P.L.).
  • Lei L; Esperion Therapeutics, Ann Arbor, MI (L.L., M.J.L.).
  • Louie MJ; Esperion Therapeutics, Ann Arbor, MI (L.L., M.J.L.).
  • Haddad T; Inova Heart and Vascular Institute, Falls Church, VA (T.H.).
  • Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Australia (S.J.N).
  • Lincoff AM; The Cleveland Clinic Heart and Vascular Institute, OH (A.M.L., S.E.N.).
  • Libby P; Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (P.M.R., P.L.).
  • Nissen SE; The Cleveland Clinic Heart and Vascular Institute, OH (A.M.L., S.E.N.).
Circulation ; 149(1): 28-35, 2024 01 02.
Article in En | MEDLINE | ID: mdl-37929602
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Myocardial Infarction Limits: Humans Language: En Journal: Circulation Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Myocardial Infarction Limits: Humans Language: En Journal: Circulation Year: 2024 Document type: Article Country of publication: